• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation.

作者信息

Koshy Anoop N, Sampaio Rodrigues Thalys, Gow Paul J, Cailes Benjamin, VanWagner Lisa B, Farouque Omar

机构信息

Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.

The University of Melbourne, Parkville, Victoria, Australia.

出版信息

Liver Transpl. 2023 Apr 1;29(4):459-462. doi: 10.1097/LVT.0000000000000090. Epub 2023 Feb 7.

DOI:10.1097/LVT.0000000000000090
PMID:36749286
Abstract
摘要

相似文献

1
Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation.肝移植评估经皮冠状动脉介入治疗后使用药物洗脱支架与简化双联抗血小板治疗。
Liver Transpl. 2023 Apr 1;29(4):459-462. doi: 10.1097/LVT.0000000000000090. Epub 2023 Feb 7.
2
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).外周动脉疾病患者冠状动脉植入药物洗脱支架后的血小板反应性及临床结局：来自ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）的分析
Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004904.
3
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.EVOLVE 短程 DAPT 研究的主要结果：生物可吸收聚合物涂层依维莫司洗脱支架治疗高出血风险患者的 3 个月双联抗血小板治疗评估。
Circ Cardiovasc Interv. 2021 Mar;14(3):e010144. doi: 10.1161/CIRCINTERVENTIONS.120.010144. Epub 2021 Mar 1.
4
The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.药物洗脱支架置入术后双联抗血小板治疗的疗程历程
Arch Cardiovasc Dis. 2015 Oct;108(10):469-71. doi: 10.1016/j.acvd.2015.09.001. Epub 2015 Oct 1.
5
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.
6
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.第二代药物洗脱支架治疗冠状动脉疾病后短期双联抗血小板治疗（≤6个月）的安全性：一项随机试验的系统评价和荟萃分析
Catheter Cardiovasc Interv. 2016 Mar;87(4):722-732. doi: 10.1002/ccd.26110. Epub 2015 Aug 26.
7
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.双联抗血小板治疗患者的药物洗脱支架或裸金属支架内血栓形成。
JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026.
8
Review of Coronary Late Breaking Trials From the TCT Connect 2020 Virtual Meeting.2020年经导管心血管治疗（TCT）连线虚拟会议冠状动脉最新试验综述
Cardiovasc Revasc Med. 2021 Jul;28:65-70. doi: 10.1016/j.carrev.2020.12.036. Epub 2021 Jan 4.
9
Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.左主干分叉经皮冠状动脉介入治疗中 2 支架策略而非 1 支架策略后双联抗血小板治疗时间决定结局。
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2453-2463. doi: 10.1016/j.jcin.2018.09.020.
10
Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? All patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy.
Circulation. 2015 Jun 2;131(22):2001-9; discussion 2009. doi: 10.1161/CIRCULATIONAHA.114.013279.

引用本文的文献

1
Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidates.肝移植候选者行有创冠状动脉造影的安全性、有效性及结果
JHEP Rep. 2025 Apr 22;7(7):101428. doi: 10.1016/j.jhepr.2025.101428. eCollection 2025 Jul.
2
LTSI Consensus Guidelines: Preoperative Cardiac Evaluation in Adult Liver Transplant Recipients.LTSI 共识指南：成人肝移植受者的术前心脏评估
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102419. doi: 10.1016/j.jceh.2024.102419. Epub 2024 Oct 18.